Clinical Trial News

Gritstone bio Inc., in collaboration with Worldwide Clinical Trials, is conducting a clinical trial of GRT C901/GRT-R902 (an investigational personalized vaccine) plus immunotherapy in patients with Advanced Stage IV Colorectal Cancer. Why is this study being done? The main purpose […]

If you have been diagnosed with muscle invasive bladder cancer, we are now offering a clinical trial for the general population. Please see the information below to learn more. If you are interested in participating in this clinical trial or […]

ECHO proudly enrolled the first patients in two genomic based studies ( MYTACTIC and KRYSTAL-7) opened within the OneOncology network. This demonstrates that innovative genomic testing affords patients the opportunity to be treated in their own community with personalized, targeted therapy.   Below […]

Exact Sciences has identified ECHO as the highest enroller nationally for the cancer cohort for their Ascend 2 clinical trial. This primary endpoint of this trial is hopefully identifying biomarkers for early detection of cancer. ECHO is recruiting healthy individuals with no […]